How on earth is it the week of Thanksgiving already? It feels like we were just moving to Wisconsin, which happened back in April. We’re already seven months into this new life of ours, and six weeks from the start of a new year. How? Why? Huh? Is anyone else…
“Definition of chronic pain: being constantly in pain. Yes, constantly. Every single second. The person is smiling? Still in pain. The person doesn’t mention it? Still in pain. The person says ‘I’m fine.’ Still in pain.” — Unknown Chronic pain has been my constant companion for the…
CAN106, an investigational complement-inhibiting therapy being developed by CANbridge Pharmaceuticals, has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) as a potential treatment for myasthenia gravis (MG). The FDA gives orphan drug status to therapies that have the potential to treat rare disorders,…
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have agreed to review applications seeking the approval of zilucoplan to treat generalized myasthenia gravis (gMG). UCB, the therapy’s developer, announced the FDA accepted its new drug application (NDA), requesting zilucoplan be approved to treat…
Inconclusive: one of the most annoying, aggravating, but reassuring words to anyone with complex health issues. Why reassuring? Because at least it’s not negative. It provides some modicum of validation. Something is showing up on whatever test results have been deemed inconclusive. Why does it matter? Many of us in…
The onset of myasthenia gravis (MG) occurs at a significantly younger age in people who smoke, a study has found. Women who smoked at MG onset, or within 10 years before its onset, were significantly younger at disease onset than men. Yet, no sex differences were seen among those…
Intravenous immunoglobulin therapy was not effective at reducing the daily dose of corticosteroids for treating myasthenia gravis (MG), a multicenter Phase 2 trial shows. “These results suggest that immunomodulation alone was insufficient to facilitate dose reduction,” the researchers wrote. The trial results were reported in the study, “…
I’d been home from the hospital after my first myasthenic crisis for about two weeks when my husband looked at me as he’d never looked at me before and asked, “Honey, do you need help with showering?” I looked at him and instantly started to cry. Who wants to admit…
Nearly six months of treatment with telitacicept (RC18), an anti-inflammatory developed by RemeGen, safely lessened disease severity in adults with myasthenia gravis (MG) positive for acetylcholine receptor (AChR) antibodies. That’s according to new data from an ongoing Phase 2 trial in China. “The latest Phase II clinical study…
Treatment with the diabetes medication metformin suppresses the growth of immune T- and B-cell subsets that are implicated in the development of myasthenia gravis (MG), according to a study in a rat model of the neuromuscular disease. Metformin appeared to exert these positive effects by reversing the abnormal levels…
Get regular updates to your inbox.
